Brasilia, Brazil, 21-23 October 2019

2019 relavra brasil participants full bg

The Pan American Health Organization (PAHO) convened the Biennial meeting of the Latin American Network for Surveillance to Antimicrobial Resistance (ReLAVRA) in Brasilia, Brazil, 21-23 October 2019 with the participation of representatives from Latin America and the Caribbean and technical partners.

One of the most important strategies to combat antimicrobial resistance (AMR) is ongoing comprehensive surveillance. Strengthening surveillance is one of the five key strategic objectives outlined in the global and regional action plans; essential for increasing awareness around the problem and inform AMR prevention actions, treatment guidelines and patient safety measures.

The meeting agenda consisted of expert and country presentations, and panel discussions covering wide range of priority technical and policy areas related to multidisciplinary enhanced AMR surveillance; and the collaborative work coordinated by PAHO and partners in the Americas.

Presentations are shown in the original language

Session 1: Introduction: Welcome remarks.

  1. Brazil progress on AMR surveillance and response
    André Luiz de Abreu, MOH General Coordinator

  2. Global perspectives on AMR
    Marc Sprenger, Director AMR, WHO HQ

Session 2: AMR Special Program Updates, Collaborations and Partners.

3. Overview of the AMR Special Program at PAHO: challenges and opportunities
Pilar Ramon-Pardo, PAHO AMR

4. Multidisciplinary approach to AMR surveillance: European Experience and Lessons Learned
Danilo Lo Fo Wong, Programme Manager AMR, EURO

5. CDC strategies and initiatives to tackle AMR: from domestic to international
Elizabeth Bancroft, CDC

6. Experiences from the field: American Society for Microbiology
Andrea Rosales, ASM

Session 3: Implementing enhanced surveillance.

7. RELAVRA role on AMR surveillance – achievements and lessons learnt
Marcelo Galas, PAHO AMR

8. Strengthening AMR surveillance in the Region and connecting to GLASS through enhanced surveillance in blood stream infections
Nienke Bruinsma, PAHO AMR

9. Countries experience: Costa Rica
Antonieta Jimenez

10. Countries experience: El Salvador
Esmeralda Reina Villatoro

11. Countries experience: Suriname
Ed Ijzerman

12. Countries experience: Peru
Willi Quino Sifuentes

Session 4: Roles and responsibilities of the laboratory on AMR surveillance.

13. External Quality Assessment Program in Latin America
Alejandra Corso, Argentina

14. Rapid phenotypic methods: what's new?
Andrea Rosales, ASM

15. New technologies applied to diagnosis: Proteomics
Mónica Prieto, Argentina

Session 5: Multidisciplinary approach to surveillance and containment of carbapenem resistant organisms (CROs)

16. Current epidemiological situation on CRO in LAC: are the surveillance systems working?
Joan Neira, PAHO PER

17. CRO’s Surveillance and Data Analyses: informing interventions & policy - what is needed at the lab and at the hospital epidemiology level
Elizabeth Bancroft, CDC

18. CRO’s Prevention and control: implementation: IPC and Stewardship integrated approach
Ana del Rio Bueno, AMR PAHO

19. Experience and lessons learnt from countries: Panama
Jose Moreno

20. Experience and lessons learnt from countries: Colombia
Maria Victoria Ovalle

21. Experience and lessons learnt from countries: Brazil
Cristina Carvalehiro

22. Experience and lessons learnt from countries: Ecuador
Fernando Villavicencio

23. Experience and lessons learnt from countries: Nicaragua
Julissa Avila

Session 6: Future steps of ReLAVRA – Conclusions and recommendations.

24. Quality and biosecurity for AMR surveillance in Latin America and the Caribbean
Jean-Marc Gabastou

25. Enhanced isolate level mycology
Maria Teresa Illait, Cuba

26. Neisseria gonorrhoeae surveillance
Loida Mercedes Gonzalez, Dominican Republic

27. Integrated surveillance – role of the food laboratories network (RILAA)
Margarita Corrales, PANAFTOSA

28. AMR Environmental surveillance
Nancy Melgarejo, Paraguay

29. PULSENET Latin America and WGS implementation
Enrique Perez Gutierrez, PAHO PHE

30. Partnerships in developing new treatments and diagnosis: GARDP / DNDi
Francisco Viegas Neves da Silva, DNDi/GARDP

31. Consensus on the stepwise approach enhanced surveillance implementation
Nienke Bruinsma, AMR PAHO